{"id":"typically-prescribed-oral-antibiotic-prophylaxis","safety":{"commonSideEffects":[{"rate":"5-15%","effect":"Gastrointestinal upset (nausea, diarrhea)"},{"rate":"1-3%","effect":"Allergic reaction (rash, urticaria)"},{"rate":"1-5%","effect":"Headache"},{"rate":"1-5%","effect":"Yeast infection (candidiasis)"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oral antibiotic prophylaxis typically involves agents such as amoxicillin or other beta-lactams that work by disrupting bacterial cell wall integrity, or macrolides/fluoroquinolones that inhibit bacterial protein synthesis. These mechanisms prevent colonization and infection in at-risk patients undergoing procedures or with specific medical conditions.","oneSentence":"Oral antibiotics prevent bacterial infection by inhibiting bacterial protein synthesis or cell wall formation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:42:08.804Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Surgical site infection prophylaxis"},{"name":"Endocarditis prophylaxis in at-risk cardiac patients"},{"name":"Urinary tract infection prophylaxis"}]},"trialDetails":[{"nctId":"NCT06953271","phase":"PHASE4","title":"Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection","status":"NOT_YET_RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-15","conditions":"Overactive Bladder (OAB), Urinary Tract Infection (Diagnosis)","enrollment":164}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Oral antibiotics"],"phase":"marketed","status":"active","brandName":"Typically prescribed oral antibiotic prophylaxis","genericName":"Typically prescribed oral antibiotic prophylaxis","companyName":"Women and Infants Hospital of Rhode Island","companyId":"women-and-infants-hospital-of-rhode-island","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oral antibiotics prevent bacterial infection by inhibiting bacterial protein synthesis or cell wall formation. Used for Surgical site infection prophylaxis, Endocarditis prophylaxis in at-risk cardiac patients, Urinary tract infection prophylaxis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}